SMA Stem Cell Treatment In India
In May 2019, the FDA approved onasemnogene abeparovec- xioi gene therapy for children less than 2 years old who have infantile-onset SMA. A safe virus delivers a fully functional human SMN gene to the targeted...
© 2023 - 2024 SCCI All rights reserved.